Exelixis (NASDAQ: EXEL) reported Q2 EPS of $0.31, $0.14 better than the analyst estimate of $0.17. Revenue for the quarter came in at $469.8 million versus the consensus estimate of $447.2 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.